Details for Patent: 11,795,178
✉ Email this page to a colleague
Which drugs does patent 11,795,178 protect, and when does it expire?
Patent 11,795,178 protects MYFEMBREE and ORGOVYX and is included in two NDAs.
This patent has thirty-eight patent family members in nineteen countries.
Drugs Protected by US Patent 11,795,178
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sumitomo Pharma | MYFEMBREE | estradiol; norethindrone acetate; relugolix | TABLET;ORAL | 214846-001 | May 26, 2021 | RX | Yes | Yes | 11,795,178 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | |||
| Sumitomo Pharma | ORGOVYX | relugolix | TABLET;ORAL | 214621-001 | Dec 18, 2020 | RX | Yes | Yes | 11,795,178 | ⤷ Subscribe | Y | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,795,178
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 092707 | ⤷ Subscribe | |||
| Canada | 2881132 | ⤷ Subscribe | |||
| China | 104703992 | ⤷ Subscribe | |||
| China | 109053766 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
